406 related articles for article (PubMed ID: 27591329)
21. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
[TBL] [Abstract][Full Text] [Related]
23. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
[TBL] [Abstract][Full Text] [Related]
24. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
[TBL] [Abstract][Full Text] [Related]
25. Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis.
Mejía-Vilet JM; Romero-Díaz J
Expert Rev Clin Immunol; 2021 Sep; 17(9):937-945. PubMed ID: 34392746
[TBL] [Abstract][Full Text] [Related]
26. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
[TBL] [Abstract][Full Text] [Related]
27. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T
Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
[TBL] [Abstract][Full Text] [Related]
29. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
Cooper JC; Rouster-Stevens K; Wright TB; Hsu JJ; Klein-Gitelman MS; Ardoin SP; Schanberg LE; Brunner HI; Eberhard BA; Wagner-Weiner L; Mehta J; Haines K; McCurdy DK; Phillips TA; Huang Z; von Scheven E;
Pediatr Rheumatol Online J; 2018 Oct; 16(1):65. PubMed ID: 30348175
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.
Jiang N; Jin S; Yu C; Zhao J; Wang Q; Tian X; Li M; Zeng X
Front Immunol; 2023; 14():1232244. PubMed ID: 37901212
[TBL] [Abstract][Full Text] [Related]
31. Lupus Nephritis in Asia: Clinical Features and Management.
Yap DY; Chan TM
Kidney Dis (Basel); 2015 Sep; 1(2):100-9. PubMed ID: 27536670
[TBL] [Abstract][Full Text] [Related]
32. Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
Argolini LM; Frontini G; Elefante E; Saccon F; Binda V; Tani C; Scotti I; Carli L; Gatto M; Esposito C; Gerosa M; Caporali R; Doria A; Messa P; Mosca M; Moroni G
J Nephrol; 2021 Apr; 34(2):389-398. PubMed ID: 32462476
[TBL] [Abstract][Full Text] [Related]
33. Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
Kawazoe M; Nanki T
Lupus; 2024 Apr; 33(4):319-327. PubMed ID: 38232223
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
Hannah J; Casian A; D'Cruz D
Autoimmun Rev; 2016 Jan; 15(1):93-101. PubMed ID: 26427983
[TBL] [Abstract][Full Text] [Related]
35. Recent Advances in Treatment Strategies for Lupus Nephritis.
Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K
Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil for lupus nephritis: an update.
Mok CC
Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis.
Lee YH; Song GG
Z Rheumatol; 2023 Nov; 82(9):754-762. PubMed ID: 36607421
[TBL] [Abstract][Full Text] [Related]
38. II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.
Reis-Neto ETD; Seguro LPC; Sato EI; Borba EF; Klumb EM; Costallat LTL; Medeiros MMDC; Bonfá E; Araújo NC; Appenzeller S; Montandon ACOES; Yuki EFN; Teixeira RCA; Telles RW; Egypto DCSD; Ribeiro FM; Gasparin AA; Junior ASA; Neiva CLS; Calderaro DC; Monticielo OA
Adv Rheumatol; 2024 Jun; 64(1):48. PubMed ID: 38890752
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
J Rheumatol; 2014 Oct; 41(10):1998-2007. PubMed ID: 25225281
[TBL] [Abstract][Full Text] [Related]
40. Long-term data on tacrolimus treatment in lupus nephritis.
Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM
Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]